How I Invest with David Weisburd
E178: Elon Musk of Biotech: How David Berry Built 7 Unicorns
23 Jun 2025
David Berry is one of the most prolific healthcare entrepreneurs of our time. In this episode, we discuss his transition from scientist to founder to investor, what it takes to scale transformational health companies, and how his firm Averin is helping usher in the next wave of AI-enabled healthcare. We also talk about his early experience launching a satellite at 14, how he's co-founded over 30 companies—including seven unicorns—and why patents, perseverance, and purpose are the trifecta behind lasting innovation.
No persons identified in this episode.
This episode hasn't been transcribed yet
Help us prioritize this episode for transcription by upvoting it.
Popular episodes get transcribed faster
Other episodes from How I Invest with David Weisburd
Transcribed and ready to explore now
E170: How an AI Agent Is Outperforming VCs w/Andrew D’Souza
04 Jun 2025
How I Invest with David Weisburd
E169: How to Build an Enduring Private Equity Franchise w/Alex Robinson
02 Jun 2025
How I Invest with David Weisburd
E168: How I Coach The Top 0.1% CEO's in Silicon Valley w/Alexis John d'Amecourt
30 May 2025
How I Invest with David Weisburd
E167: The Hardest Questions Limited Partners Ask GPs w/Stepstone’s Hunter Somerville
27 May 2025
How I Invest with David Weisburd
E166: $20 Billion CIO: Why Small Cap Stocks Have Underperformed (and why that’s unlikely to change) w/Brad Conger
23 May 2025
How I Invest with David Weisburd
E165: Hollywood Lessons on Risk, Reward, and Relationships with Alexander Ludwig
20 May 2025
How I Invest with David Weisburd